CTSB and cancer: The fabricated ApoLNPs were assessed for their size, cathepsin B-specific activatability, and cytotoxicity against normal and cancer cells, then they were intratumorally administered via MSC guidance to monitor their tumor accumulation efficiency compared to its intravenous or direct intratumoral administration without MSC (Scheme 1b).